SCHEMBL18034519

SCHEMBL18034519

CC(CO)C1OC(=O)C=C2C1CC1OC(=O)[C@@]3(C)CCC[C@@]2(C)C13

nearest known ligand 0.40

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ JUN P05412 1/20 0.40
▸ TTL Q8NG68 1/20 0.33
▸ STAT3 P40763 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18034508 0.85 LMNA (0.33) STAT3
SCHEMBL29709940 0.67 JUN (0.78) JUNTTLSTAT3
SCHEMBL7496026 0.60 JUN (0.38) JUNTTL
SCHEMBL18290209 0.58 KARS1 (0.50) JUN
Yukonin SCHEMBL7493922 0.56 JUN (0.70) JUNTTL
SCHEMBL18034517 0.55 JUN (0.57) JUNSTAT3
SCHEMBL7974137 0.52 JUN (0.67) JUN
SCHEMBL12464454 0.50 HIF1A (0.33) —
SCHEMBL20009694 0.50 HIF1A (0.39) —
SCHEMBL12604242 0.49 TSHR (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016131426-A1 NAGILACTONE COMPOUNDS HAVING ANTILIPEMIC ACTIVITY, PREPARATION METHOD THEREFOR AND USES THEREOF 中国科学院上海药物研究所 2016-08-25 — — WO disclosed
Send feedback